The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.
about
Arterial Therapies of Non-Colorectal Liver MetastasesHow Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour groupSafety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results.Clinical Interventional Oncology Symposium And Integrative Healthcare SymposiumRole of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.Current role of selective internal radiation with yttrium-90 in liver tumors.Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentLong-Term Survival of a Patient with Metastatic Small-Cell Carcinoma of the Stomach Treated with Radiation Therapy.The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.Liver transarterial embolizations in metastatic neuroendocrine tumors.Characterization of 90 Y-SPECT/CT self-calibration approaches on the quantification of voxel-level absorbed doses following 90 Y-microsphere selective internal radiation therapy.The Evolution of Neuroendocrine Tumor Treatment reflected by ENETS Guidelines.Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer
P2860
Q26764990-281505A5-DC19-44AD-9A93-CB8F06598B4EQ26764993-B76B6806-7929-40E8-869A-E14F5105D8F8Q33737587-07F382D2-7DAE-43BC-A8BA-FF759C56659BQ37525291-357AFFC3-D97E-49A1-AF29-9E50E36918D7Q37629658-0E71EC68-5BBC-4D05-B324-CE4F2629CBBEQ37671474-59B3A806-D080-468A-ADD6-544CBB7A3A56Q37711918-E1A88D67-F8C1-4331-B6D4-D5E5E0591D10Q38581192-3B536C70-28AC-4A0D-832C-030430C8BA1CQ38786064-EA014201-D10B-4D9F-82A0-6192149012EBQ40071417-91DD044F-A9E8-4B7C-ADAD-29E642E41AF6Q41475179-2DAE7B62-630B-456A-9ADA-6F23380AE4A1Q42118415-2913B6CE-DA6B-419B-92C1-B92E6D9569F9Q46141893-4D8BDAA0-A3FE-4ADD-81AF-39FB3FE20F4DQ47134709-314201BD-965F-46A9-BC6E-E7A475B77B9CQ47869784-6F733DBB-C0B6-4856-822D-0169A4A05ADCQ49672113-C3C50C18-5859-4B7A-97A5-7FB3F213CC1CQ50103017-619E4FF8-071E-4D2D-92E8-F02F82DAB934Q55434794-67B87EDB-6B66-441C-BF92-A08AF67E68BBQ58702255-13E8B762-43F7-4FD9-A3B3-81F38F0D7FA7
P2860
The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The efficacy of hepatic 90Y re ...... crine tumors: a meta-analysis.
@en
type
label
The efficacy of hepatic 90Y re ...... crine tumors: a meta-analysis.
@en
prefLabel
The efficacy of hepatic 90Y re ...... crine tumors: a meta-analysis.
@en
P2093
P1476
The efficacy of hepatic 90Y re ...... ocrine tumors: a meta-analysis
@en
P2093
Arjun Banerjee
Daniel Y Sze
Jarrett Rosenberg
Marnix G E H Lam
Tust Techasith
Zlatko Devcic
P304
P356
10.2967/JNUMED.113.135855
P407
P577
2014-07-10T00:00:00Z